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PRECLINICAL STUDIES
hickening of the Infarcted Wall by Collagen
njection Improves Left Ventricular Function in Rats
Novel Approach to Preserve
ardiac Function After Myocardial Infarction
angde Dai, MD, Loren E. Wold, PHD, Joan S. Dow, BS, Robert A. Kloner, MD, PHD
os Angeles, California
OBJECTIVES We determined whether collagen implantation could thicken the infarcted left ventricular
(LV) wall and improve LV function.
BACKGROUND We hypothesized that thickening the infarcted wall by using collagen might result in some
benefits that are similar to what previously had been reported when the infarcted wall was
thickened with cells.
METHODS Fischer rats with one-week-old myocardial infarcts were injected with collagen or saline (100 l)
into the scar (n  12 each group). Six weeks later, LV angiograms, hemodynamics, and
regional myocardial blood flow were assessed. The hearts were processed for measurements of
postmortem LV volume and histology.
RESULTS Collagen injection significantly increased scar thickness (719  26 m) compared with the
saline-treated group (440  34 m, p  2.6  106). By LV angiography, stroke volume was
significantly larger in the collagen-treated group (163  8 l) than in the saline-treated group
(129  6 l, p  0.005), and LV ejection fraction was also greater in the collagen-treated group
(48.4 1.8%) than in the saline-treated group (40.7 1.0%, p 0.002). Analysis of regional wall
motion demonstrated paradoxical systolic bulging in 5 of 10 saline-treated rats that averaged 20.3
 2.6% of the LV diastolic circumference, but in none of the 11 collagen-treated rats (p 0.012).
The LV end-diastolic and end-systolic volumes were 319  12 l and 190  7 l in the
saline-treated group, respectively. There was a trend for larger LV end-diastolic volumes (343 
23 l), but smaller end-systolic volumes (180  16 l) in the collagen-treated group.
CONCLUSIONS This study shows that collagen injection thickens an infarct scar and improves LV stroke volume
and ejection fraction, and prevents paradoxical systolic bulging after myocardial
infarction. (J AmColl Cardiol 2005;46:714–9) © 2005 by the American College of Cardiology
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.056Foundation
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ifter a proximal coronary artery occlusion, a wave front of
ecrosis progresses from the subendocardium to the subepi-
ardium of the left ventricle (LV) within the area at risk (1).
pproximately 15 min after severe ischemia, necrosis starts
n the subendocardium and becomes transmural by about six
of occlusion. Within the first weeks of an extensive
yocardial infarction (MI), the necrotic tissue stretches and
hins as the collagen matrix holding the myocytes together
isintegrates, allowing the necrotic myocytes to slip past
ach other (slippage) (2). This phenomenon is termed
nfarct expansion and results in some degree of early LV
ilation. Over time, the infarct and noninfarct zones con-
inue to thin and stretch; within the noninfarcted wall,
ccentric hypertrophy develops over weeks to months as
arcomeres are added to the myocytes in a longitudinal
ashion. This contributes further to LV dilation and, even-
ually, decompensation with congestive heart failure. These
From The Heart Institute, Good Samaritan Hospital, Division of Cardiovascular
edicine, Keck School of Medicine, University of Southern California, Los Angeles,
alifornia. This study was supported in part by National Heart, Lung, and Bloodp
nstitute Grant R01-HL073709.
Manuscript received March 18, 2005, accepted April 20, 2005.opographical changes that occur within the LV after acute
I—infarct expansion, concentric hypertrophy, and LV dila-
ion—have been described as LV remodeling after acute MI.
Paradoxical systolic bulging caused by infarct expansion
nd thinning can impair LV systolic function (3). Recently,
e have observed that injection of neonatal cardiomyocytes
nto the thinned infarct wall of rats subjected to acute MI
ncreased scar thickness and improved regional wall motion—
articularly reducing the degree of dyskinesis of the infarct
one (3). The benefit of preventing paradoxical systolic
ulging that was observed might be due to the contractile
otential of the implanted myocytes or related to passive
hickening of the scar. By simply thickening and toughening
he infarct scar, paradoxical systolic bulging should be
educed, wall stress should be reduced, and forward cardiac
utput improved. In the present study, we determined the
easibility and tolerability of injecting commercially avail-
ble collagen into an infarct wall and whether collagen
mplantation can have many of the same benefits as cell
ransplantation, including: improving the thickness of the
nfarcted LV wall, improving global LV function, and
reventing paradoxical systolic bulging.
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ll of the experiments were performed in accordance with
he “Guide for the Care and Use of Laboratory Animals”
National Institutes of Health Publication No. 85-23,
ational Academy Press, Washington, DC, revised 1996)
nd approved by the Institutional Animal Care and Use
ommittee. The Heart Institute in Good Samaritan Hos-
ital is accredited by the American Association for Accred-
tation of Laboratory Animal Care.
ollagen for implanting. Zyderm collagen implant
Zyderm type 2) was obtained from INAMED Corp.
Santa Barbara, California). It is a sterile compound com-
osed of highly purified bovine dermal collagen (65 mg/ml)
hat consists of 95% collagen I and 5% collagen III. Zyderm
ollagen is used clinically for correction of contour deficien-
ies of soft tissue.
odel of MI and collagen injection. Myocardial infarc-
ion was performed by ligation of the proximal left coronary
rtery through a left thoracotomy under anesthesia with
etamine (75 mg/kg intraperitoneal) and xylazine (5 mg/kg
ntraperitoneal) in female Fischer CDF rats (Charles River
aboratories, Wilmington, Massachusetts) as described
reviously (3). One week later, the rats were re-anesthetized
s described above. The hearts were exposed through a
econd thoracotomy, and collagen (100 l Zyderm type 2
6.5 mg highly purified bovine dermal collagen; n  12)
r saline (100 l, n  12) was injected directly into the
nfarct area with a 28-gauge needle attached to an insulin
yringe. The rats were allowed to recover and housed in a
lean laboratory room with a temperature-controlled envi-
onment under a 12-h light-dark cycle and fed with free
ccess to food and water for 6 weeks.
n vivo ventriculography. Left ventricular contrast an-
iography was performed with a XiScan 1000 C-arm X-ray
ystem (XiTec Inc., East Windsor, Connecticut; 3-inch
eld of view). Rats were anesthetized at six weeks after
njection, and a catheter was inserted into the left jugular
ein. After the injection of 1 ml nonionic contrast into the
eft jugular vein, video images (anterior-posterior and lateral
rojections) were acquired on half-inch super-VHS video-
ape at 30 frames/s under constant fluoroscopy. The video
mages were analyzed off-line, blindly, to calculate LV
olumes in systole and diastole. All parameters were aver-
ged over three consecutive cycles in both projections.
jection fraction (EF) (%) was calculated as: 100 (volume
n diastole  volume in systole)/volume in diastole, and
Abbreviations and Acronyms
dp/dt  change in pressure over time
EF  ejection fraction
LV  left ventricle/ventricular
MI  myocardial infarction
RMBF  regional myocardial blood flowveraged over both projections. assessment of paradoxical systolic bulging. Tracings ob-
ained from the LV angiograms during end-diastole and
nd-systole of the same cardiac cycle of three consecutive
eats were superimposed on transparent film and were
ompared between groups in both the anterior-posterior
nd lateral views. Bulging was evident if the tracing from
nd-systole was not confined within that of end-diastole. In
rder to calculate the size of paradoxical LV systolic
ulging, the length of total LV diastolic circumference and
ircumferential length of the bulging segment were mea-
ured with computerized planimetry.
emodynamics. For hemodynamic measurements, a 2-F
igh-fidelity, catheter-tipped micromanometer (model
PR-869, Millar Inc., Houston, Texas) was advanced into
he ascending aorta and LV through the right carotid artery
o record aorta and LV hemodynamic parameters.
egional myocardial blood flow (RMBF). In order to
easure RMBF, 103ruthenium-labeled radioactive micro-
pheres (500,000) were injected directly into the LV, and
reference blood sample was withdrawn simultaneously
rom an arterial catheter (0.361 ml/min) for 1 min. Radio-
ctivity in the scar tissue, the noninfarcted myocardium, and
n the reference blood sample was counted in a multi-
hannel pulse-height analyzer (model ND62, Nuclear Data,
chaumburg, Illinois). After correction for background,
MBF was calculated as the ratio of counts in the tissue and
he reference blood sample multiplied by pump flow (0.361
l/min) and divided by the weight of the tissue.
ostmortem LV volumes, wall thickness, infarct sizes of
earts. Intravenous injection of 0.6 ml 50% Unisperse blue
Ciba Geigy, Hawthorne, New York), a suspension of blue
articles, was performed to stain the capillaries in the
ollagen injection area. Under deep anesthesia, the rats were
uthanized with 2 mEq potassium chloride intravenously to
rrest the heart in diastole, and a cardiectomy was per-
ormed. The LVs were pressure-fixed (pressure  13 cm
ater column) in formalin, and the volumes of LV were
easured by filling the cavity with water and weighing,
epeated three times.
Formalin-fixed hearts were cut into three transverse
lices. The middle slice was embedded in paraffin for
istology, and the other two slices were used for RMBF
nalysis. The paraffin-embedded tissue was sectioned
5-m thickness) and stained with hematoxylin and eosin
nd picrosirius red. Histological images of the stained
ections were traced with computerized planimetry, and the
ollowing parameters were measured: 1) scar thickness
average of five equidistant measurements), right ventricular
ree wall thickness, and septum thickness (average of three
quidistant measurements); 2) epicardial circumference and
ndocardial circumference; and 3) circumference occupied
y noninfarcted muscle and collagen. Septal fibrosis was
ssessed through calculating collagen deposition area in the
eptum. Picrosirius red staining slices, in which the collagen
tained red, were used to quantify the collagen deposition
rea. We used a 10  objective lens with a 100-square grid
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ontained red color or negative if they did not. The degree
f collagen deposition was expressed as a percentage of
ositive squares. Verhoeff’s stain for elastic tissue staining
as performed to detect the elastic fibers within the collagen
mplant.
tatistics. All data are presented as mean  SEM. Com-
arison between groups was made by Student t test, or
isher exact test, where appropriate. Results were consid-
red statistically significant if p  0.05.
ESULTS
total of 24 rats initially were included in this study. One
at in the phosphate-buffered saline group died after the
hest was closed and the intubation tube was removed
uring the second surgery. One rat in the collagen group
ied one day after collagen injection. Of the 22 successful
ats, one rat in the saline group was excluded because no
vidence of MI was found in the heart. The LV angio-
raphic analysis, postmortem volume measurements, and
istological analyses were performed in 11 collagen-treated
ats and 10 saline-treated rats.
V volume and EF by angiography. In the saline group,
V end-diastolic and end-systolic volumes were 319  12
l and 190 7 l, respectively. The stroke volume was 129
6 l. The EF was 40.7  1.0%. In the collagen-treated
roup, there was a trend for larger LV end-diastolic volumes
343  23 l) and smaller end-systolic volumes (180  16
l) and significantly higher stroke volume (163  8 l, p 
.005) and greater EF (48.4  1.8%, p  0.002) compared
ith the saline group (Fig. 1).
aradoxical LV systolic bulging. In the saline-treated
roup, 5 of 10 rats showed paradoxical LV systolic bulging
dyskinesis). The extent of the paradoxical LV systolic
ulging, expressed as percentage of total LV diastolic
ircumference, was 20.3  2.6% in these saline-treated rats.
igure 1. Left ventricular ejection fraction (LVEF) calculated by angiog-
aphy at six weeks after collagen or saline injection directly into the scar
rea of myocardial infarction in rats. For rats that received collagen, LVEF
as 48.4  1.8% (n  11). For rats that received saline, LVEF (40.7 a
.0%, n  10) was significantly lower than that in the collagen-treated
roup (*p  0.002).aradoxical LV systolic bulging was absent in all 11 rats
reated with collagen (p  0.012). Collagen injection
ignificantly prevented asynchronous wall motion after MI.
emodynamics. No significant differences were noted in
eart rate, systolic and diastolic blood pressure, LV positive
hange in pressure over time (dp/dt), and negative dp/dt
etween the two groups (Table 1).
MBF. Although RMBF in the scar tissue and noninfarct
issue was comparable between the two groups (Table 1),
here was a nonsignificant trend for lower RMBF in scar
issue in the collagen-treated group (0.47  0.10 ml/min/g,
 9) compared with the saline group (0.69  0.15
l/min/g, n  8, p  0.22).
ostmortem LV volumes, wall thickness, noninfarct and
nfarct LV wall sizes, expansion index, and histology. Post-
ortem LV volume was comparable between the saline-
reated group (337  17 l) and the collagen-treated
roup (325  20 l, p  0.64). Collagen injection
ignificantly increased scar thickness (719  26 m)
ompared with the saline group (440  34 m, p  2.6
106) (Table 1), but did not increase collagen depo-
ition in the septum and did not change right ventricular
ree wall thickness (Table 1).
The length of the epicardial and endocardial circumferences
as comparable between the two groups (Table 1). The
ercentage of total LV circumference composed of collagen
as significantly larger, whereas the noninfarcted LV wall, also
xpressed as a percentage of the total LV circumference, was
ignificantly smaller in the collagen-treated group (Table 1).
he expansion index as defined by Hochman and Choo (4),
hich is expressed as LV cavity area/total LV area  septum
hickness/scar thickness, was significantly reduced in the
ollagen-treated group (Table 1).
Implanted collagen in the scar tissue was easily identified
istologically as homogeneous bright red tissue on picro-
irius red staining and no bundle formation of newly
enerated host collagen (Figs. 2 and 3). Hematoxylin and
osin staining demonstrated no cellular infiltration (inflam-
ation) within the homogeneous collagen implant (Fig. 4).
erhoeff’s stain for elastic tissue staining found that no
lastic fibers were present within the homogeneous collagen
mplant (Fig. 5). The in vivo histologic appearance of the
ollagen implant was virtually identical to the in vitro
ppearance (Fig. 3D). Angiogenesis was not observed,
ecause no blue particles appeared in the implanted collagen
rea (Figs. 3 and 4).
ISCUSSION
his study demonstrates for the first time that collagen
mplanted into the scar of a MI remained in the infarct zone
or up to six weeks and did not induce an inflammatory
esponse or immuno-rejection. Injection of collagen signif-
cantly increased scar thickness, prevented stretch of the
oninfarcted zone, and improved LV stroke volume and EF
fter MI compared with saline injection. Improvement in
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een largely due to a prevention of paradoxical systolic
ulging observed in the collagen group.
A novel approach to preserve cardiac function after MI is
mplanting biomedical materials into an infarcted area as an
nternal support. Christman et al. (5) injected fibrin glue
nto one-week-old myocardial infarcts as an internal support
nd found this treatment preserved cardiac function at five
eeks after injection; however, they did not know the exact
echanism by which fibrin glue preserved cardiac function.
ibrin glue might have worked by inducing neovasculature
ormation in the infarct area and/or attenuating the decrease
n infarct wall thickness. In our present study, collagen
njection attenuated the decrease in infarct wall thickness
ithout neovasculature formation in the collagen implant.
Table 1. Parameters of LV Function and Post
Angiographic analysis
LV end-diastolic volume (l)
LV end-systolic volume (l)
Stroke volume (l)
LV ejection fraction (%)
Hemodynamics
Heart rate (beats/min)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
dp/dt (mm Hg/s)
dp/dt (mm Hg/s)
Postmortem analysis
Postmortem LV volume (l)
% of LV circumference composed of collagen
% of LV circumference in the noninfarcted zone
Scar thickness (m)
Septum thickness (m)
Right ventricular free wall thickness (m)
Collagen deposition in septum (%)
Infarct expansion index
Regional myocardial blood flow
Scar tissue (ml/min/g)
Noninfarct tissue (ml/min/g)
Scar/noninfarct tissue (%)
*Statistically significant.
LV  left ventricle/ventricular.
igure 2. (A) Low-power slices of left ventricles stained with picrosirius r
hows that implanted collagen thickens the wall (blue arrows) of the six-w
eart with six-week-old myocardial infarct (black arrows). Note the staining of
ess intense than that of the implanted collagen (bright red staining).hus, our data support the hypothesis that internal support
f the infarct wall by biomedical materials can preserve
ardiac function by thickening the infarct wall and without
eovascularization. The advantages of collagen injection are
hat commercially prepared collagen is readily available, it
an be injected early (before infarct expansion is complete),
t is relatively inert (will not induce a rejection phenome-
on), and is easy to inject into the scar. Compared with cell
ransplantation, collagen injection did not improve systolic
nd diastolic blood pressure and positive and negative dp/dt.
he explanation might be that collagen injection did not
ffect the LV contractile ability, whereas the cell transplan-
ation did. Although this study shows that collagen can
hicken the scar, improve EF and stroke volume, and
revent paradoxical systolic bulging, the long-term effects
m Morphometry
ollagen Group Saline Group p Value
343  23 319  12 0.37
180  16 190  7 0.59
163  8 129  6 0.005*
48.4  1.8 40.7  1.0 0.002*
251  5 246  10 0.64
145  4 142  9 0.74
112  2 106  6 0.38
5,347  394 5,646  596 0.68
3,468  361 3,507  463 0.95
325  20 337  17 0.64
48.9  2.0 41.2  2.3 0.02*
51.1  2.0 58.8  2.3 0.02*
719  26 440  34 2.6  106*
912  19 876  47 0.45
546  49 520  62 0.75
15.4  0.8 15.3  0.9 0.96
0.78  0.04 1.30  0.12 0.0003*
0.47  0.10 0.69  0.15 0.22
1.72  0.36 2.04  0.43 0.59
31.5  7.5 37.1  6.1 0.58
ining. Muscle cells stain yellow, whereas collagen stains red. The section
ld myocardial infarct scar area with bright red collagen. (B) Saline-treatedmorte
Ced sta
eek-othe infarct scar collagen in the thin free wall of the left ventricle is much
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nown, such as how long the collagen can stay in the infarct
rea and whether the collagen is ultimately colonized by
ost connective tissue.
Another potential benefit of collagen injection is that by
reventing scar shrinkage it might limit noninfarct LV
tretching and eccentric hypertrophy of the noninfarcted
V. Roberts et al. (6) found that the infarcted tissue
igure 3. (A, B) Higher power view of the boxed area in Figure 2A. Picros
he bright red-stained implanted collagen is in the center of the scar (A, B
A: 40; B: 100). (C) Higher power view (400) of Figure 3B show th
ollagen deposition (right side). The collagen implant is homogeneous. Th
taining of in vitro collagen for implantation. The collagen staining is brig
400). (E, F) Higher power view of the boxed area in Figure 2B. Picrosi
rea. Red staining shows the collagen deposition, whereas yellow shows th
E: 40; F: 100). In contrast, note that no blue dye is found in the impla
ntense in Figures 3A and 3B (collagen-treated) compared with Figures 3
igure 4. (A, B) Hematoxylin and eosin staining of the slices in Figure 2A
mplant (left side) and the native collagen deposition (right side). The col
ollagen deposition shows bundle formation with cells (yellow arrows) (A: 2
mplantation. The collagen staining is bright red and homogeneous, similar toontracted, whereas noninfarcted tissue expanded during
epair of the infarct 21 days after MI in rats. It is possible
hat scar contraction contributed to compensatory expan-
ion of noninfarcted myocardium (eccentric hypertrophy)
ith eventual volume overload. This compensatory hyper-
rophy of noninfarcted myocardium after MI in the rat
odel was also observed by other groups (7). Holmes et al.
8) observed scar shrinkage after coronary ligation in the
ed-stained sections of collagen implanted into myocardial infarct scar area.
k arrows), and the scar is divided into endocardial and epicardial portions
er (black arrows) between the collagen implant (left side) and the native
no bundle formation as in native collagen deposition. (D) Picrosirius red
and homogeneous, similar to that shown in Figure 3C (collagen-treated)
d-stained sections of a six-week-old saline-treated myocardial infarct scar
le myocardium in the scar, and the blue staining shows the blood vessels
collagen area in Figures 3A and 3B, and collagen deposition is much more
3F (saline-treated).
white dashed line (white arrow) shows the border between the collagen
implant is homogeneous red without cells within the implant. The nativeirius r
; blac
e bord
ere is
ht red
rius re
e viab. The
lagen00, B: 400). C Hematoxylin and eosin staining of in vitro collagen for
that shown in Figure 4B (collagen-treated) (400).
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August 16, 2005:714–9 Collagen Injection and Myocardial Infarctionig. The infarct scar contraction and the compensatory
ypertrophy of noninfarcted myocardium might contribute
o diastolic dysfunction caused by abnormal ventricular
hamber stiffness (9). In the present study, the percent of
he LV circumference composed of collagen was, of course,
reater in the collagen group, whereas the noninfarcted
yocardial circumference was significantly greater in the
aline group than in the collagen injection group. Our data
upport the concept that collagen injection might have
imited the development of eccentric (length-wise) hyper-
rophy of the noninfarcted myocardium.
In conclusion, our data suggest that collagen injection
nto the scar after MI can thicken the scar, improve LV
igure 5. Verhoeff’s stain for elastic tissue staining of the slices in Figure
A. Elastic fibers stain black, whereas collagen stains red. The white
ashed line (white arrow) shows the border between the collagen implant
left side) and the native collagen deposition (right side). The collagen
mplant is homogeneous without elastic fibers within the implant. The
ative collagen deposition demonstrates bundle formation with elastic
bers (yellow arrows) (400).troke volume and EF, and limit paradoxical systolic bulgingompared with saline-treated animals. Collagen injection
as many of the same benefits as cell transplantation
herapy, but might be a lower cost and technically easier
ption. This study suggests that implantation of biomedical
aterials into an MI as an internal support can provide a
ovel approach to preserve cardiac function after MI.
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